ID

44512

Description

Ulinastatin Preventing Postoperative Hepatic Failure in Hepatocellular Carcinoma (HCC); ODM derived from: https://clinicaltrials.gov/show/NCT01643447

Lien

https://clinicaltrials.gov/show/NCT01643447

Mots-clés

Versions (2)
  1. 20/02/2020 20/02/2020 -
  2. 27/09/2021 27/09/2021 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

27 septembre 2021

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Hepatocellular Carcinoma NCT01643447

Anglais

Eligibility Hepatocellular Carcinoma NCT01643447

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. male or female patients > 35 years and <=55 years of age.
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
2. confirmed case (patients with hcc)
Description

Liver carcinoma

Type de données

boolean

Alias
UMLS CUI [1]
C2239176
3. tumors can be radical removed and resection volume was 50% to 70%.
Description

Tumors Radical excision Possible | Excision Volume Percentage

Type de données

boolean

Alias
UMLS CUI [1,1]
C0027651
UMLS CUI [1,2]
C0184918
UMLS CUI [1,3]
C0332149
UMLS CUI [2,1]
C0728940
UMLS CUI [2,2]
C0449468
UMLS CUI [2,3]
C0439165
4. criteria of liver function: child a level, serum bilirubin ≤ 1.5 times the upper limit of normal value,alanine aminotransferase and aspartate aminotransferase ≤ 2 times the upper limit of normal value.
Description

Liver function Child-Pugh Classification | Serum total bilirubin measurement | Alanine aminotransferase measurement | Aspartate aminotransferase measurement

Type de données

boolean

Alias
UMLS CUI [1,1]
C0232741
UMLS CUI [1,2]
C4050412
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0201836
UMLS CUI [4]
C0201899
5. no dysfunction in major organs; blood routine, kidney function, cardiac function and lung function are basically normal. hbg ≥ 90g/l, wbc ≥ 3.000 cells/mm³,platelets ≥
Description

Absence Dysfunction Organ Major | Hematologic function | Renal function | Cardiac function | Pulmonary function | Hemoglobin measurement | White Blood Cell Count procedure

Type de données

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C3887504
UMLS CUI [1,3]
C0178784
UMLS CUI [1,4]
C0205164
UMLS CUI [2]
C0221130
UMLS CUI [3]
C0232804
UMLS CUI [4]
C0232164
UMLS CUI [5]
C0231921
UMLS CUI [6]
C0518015
UMLS CUI [7]
C0023508
80.000 cells/mm³.
Description

Platelet Count measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0032181
6. karnofsky performance score performance over 60.
Description

Karnofsky Performance Status

Type de données

boolean

Alias
UMLS CUI [1]
C0206065
7. patients who can understand this trial and have signed information consent.
Description

Comprehension Study Protocol | Informed Consent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0162340
UMLS CUI [1,2]
C2348563
UMLS CUI [2]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. patients who have undergone previous treatment by ulinastatin.
Description

ulinastatin

Type de données

boolean

Alias
UMLS CUI [1]
C0077906
2. patients with apparent cardiac, pulmonary, cerebronic and renal dysfunction, which may affect the treatment of liver cancer.
Description

Cardiac dysfunction | Pulmonary Dysfunction | Other Coding | Renal dysfunction | Interference Therapy Liver carcinoma

Type de données

boolean

Alias
UMLS CUI [1]
C3277906
UMLS CUI [2]
C1709770
UMLS CUI [3]
C3846158
UMLS CUI [4]
C3279454
UMLS CUI [5,1]
C0521102
UMLS CUI [5,2]
C0087111
UMLS CUI [5,3]
C2239176
3. patients with other diseases which may affect the treatment mentioned here.
Description

Disease Affecting Therapy

Type de données

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0087111
4. patients with medical history of other malignant tumors.
Description

Cancer Other

Type de données

boolean

Alias
UMLS CUI [1]
C1707251
5. subjects participating in other clinical trials.
Description

Study Subject Participation Status | Clinical Trial

Type de données

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0008976
6. extrahepatic metastasis, portal vein or other major vascular involvement. liver function: child b c.
Description

Neoplasm Metastasis Extrahepatic | Portal vein Involvement | Involvement Vascular Major | Liver function Child-Pugh Classification

Type de données

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C1517058
UMLS CUI [2,1]
C0032718
UMLS CUI [2,2]
C1314939
UMLS CUI [3,1]
C1314939
UMLS CUI [3,2]
C1801960
UMLS CUI [3,3]
C0205164
UMLS CUI [4,1]
C0232741
UMLS CUI [4,2]
C4050412
7. patients would not sign the consent to the trial.
Description

Informed Consent Unwilling

Type de données

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0558080
Retour au début de la page

Similar models

Eligibility Hepatocellular Carcinoma NCT01643447

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
1. male or female patients > 35 years and <=55 years of age.
boolean
C0001779 (UMLS CUI [1])
Liver carcinoma
Item
2. confirmed case (patients with hcc)
boolean
C2239176 (UMLS CUI [1])
Tumors Radical excision Possible | Excision Volume Percentage
Item
3. tumors can be radical removed and resection volume was 50% to 70%.
boolean
C0027651 (UMLS CUI [1,1])
C0184918 (UMLS CUI [1,2])
C0332149 (UMLS CUI [1,3])
C0728940 (UMLS CUI [2,1])
C0449468 (UMLS CUI [2,2])
C0439165 (UMLS CUI [2,3])
Liver function Child-Pugh Classification | Serum total bilirubin measurement | Alanine aminotransferase measurement | Aspartate aminotransferase measurement
Item
4. criteria of liver function: child a level, serum bilirubin ≤ 1.5 times the upper limit of normal value,alanine aminotransferase and aspartate aminotransferase ≤ 2 times the upper limit of normal value.
boolean
C0232741 (UMLS CUI [1,1])
C4050412 (UMLS CUI [1,2])
C1278039 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0201899 (UMLS CUI [4])
Absence Dysfunction Organ Major | Hematologic function | Renal function | Cardiac function | Pulmonary function | Hemoglobin measurement | White Blood Cell Count procedure
Item
5. no dysfunction in major organs; blood routine, kidney function, cardiac function and lung function are basically normal. hbg ≥ 90g/l, wbc ≥ 3.000 cells/mm³,platelets ≥
boolean
C0332197 (UMLS CUI [1,1])
C3887504 (UMLS CUI [1,2])
C0178784 (UMLS CUI [1,3])
C0205164 (UMLS CUI [1,4])
C0221130 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C0232164 (UMLS CUI [4])
C0231921 (UMLS CUI [5])
C0518015 (UMLS CUI [6])
C0023508 (UMLS CUI [7])
Platelet Count measurement
Item
80.000 cells/mm³.
boolean
C0032181 (UMLS CUI [1])
Karnofsky Performance Status
Item
6. karnofsky performance score performance over 60.
boolean
C0206065 (UMLS CUI [1])
Comprehension Study Protocol | Informed Consent
Item
7. patients who can understand this trial and have signed information consent.
boolean
C0162340 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
ulinastatin
Item
1. patients who have undergone previous treatment by ulinastatin.
boolean
C0077906 (UMLS CUI [1])
Cardiac dysfunction | Pulmonary Dysfunction | Other Coding | Renal dysfunction | Interference Therapy Liver carcinoma
Item
2. patients with apparent cardiac, pulmonary, cerebronic and renal dysfunction, which may affect the treatment of liver cancer.
boolean
C3277906 (UMLS CUI [1])
C1709770 (UMLS CUI [2])
C3846158 (UMLS CUI [3])
C3279454 (UMLS CUI [4])
C0521102 (UMLS CUI [5,1])
C0087111 (UMLS CUI [5,2])
C2239176 (UMLS CUI [5,3])
Disease Affecting Therapy
Item
3. patients with other diseases which may affect the treatment mentioned here.
boolean
C0012634 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
Cancer Other
Item
4. patients with medical history of other malignant tumors.
boolean
C1707251 (UMLS CUI [1])
Study Subject Participation Status | Clinical Trial
Item
5. subjects participating in other clinical trials.
boolean
C2348568 (UMLS CUI [1])
C0008976 (UMLS CUI [2])
Neoplasm Metastasis Extrahepatic | Portal vein Involvement | Involvement Vascular Major | Liver function Child-Pugh Classification
Item
6. extrahepatic metastasis, portal vein or other major vascular involvement. liver function: child b c.
boolean
C0027627 (UMLS CUI [1,1])
C1517058 (UMLS CUI [1,2])
C0032718 (UMLS CUI [2,1])
C1314939 (UMLS CUI [2,2])
C1314939 (UMLS CUI [3,1])
C1801960 (UMLS CUI [3,2])
C0205164 (UMLS CUI [3,3])
C0232741 (UMLS CUI [4,1])
C4050412 (UMLS CUI [4,2])
Informed Consent Unwilling
Item
7. patients would not sign the consent to the trial.
boolean
C0021430 (UMLS CUI [1,1])
C0558080 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial